Literature DB >> 28486005

Reference Values for Assessment of Unilateral Limb Lymphedema with Dual-Energy X-Ray Absorptiometry.

Caroline A Gjorup1, Helle W Hendel2, Tobias W Klausen3, Bo Zerahn2, Lisbet R Hölmich1.   

Abstract

INTRODUCTION: The clinical assessment of unilateral limb lymphedema is commonly based on measurements of interlimb volume differences. Reference values for interlimb percentage differences of the volume, fat mass, and lean mass measured with dual-energy X-ray absorptiometry (DXA) scan are, however, not established. The aim of the study was to establish and categorize these reference values in normal limbs. METHODS AND
RESULTS: DXA scans of the normal arms of 167 and normal legs of 196 melanoma patients (aged 18-75 years, body mass index <40), respectively, were performed. The interlimb percentage difference is calculated as follows: ("Limb-of-interest"-contralateral)/contralateral × 100. The interlimb percentage differences for the limb-of-interest were stratified to upper (according to handedness) and lower limbs and categorized as none/mild, moderate, or severe, respectively, based on whether the value is below, in between, or above the two prediction limits. The prediction limits for interlimb total volume percentage difference were 6% and 10%, 0% and 4%, and 3% and 6% for the dominant arm, nondominant arm, and leg, respectively. Further data are given for interlimb percentage differences of regional (upper arm, lower arm, hand, thigh, lower leg, and foot) and total volume, fat mass, and lean mass, respectively.
CONCLUSIONS: The provided clinical reference values allow for identifying and categorizing pathophysiological differences of limbs-of-interest and evaluating tissue composition.

Entities:  

Keywords:  DXA; fat mass; lean mass; limb; lymphedema; volume

Mesh:

Year:  2017        PMID: 28486005     DOI: 10.1089/lrb.2016.0064

Source DB:  PubMed          Journal:  Lymphat Res Biol        ISSN: 1539-6851            Impact factor:   2.589


  4 in total

1.  Primary lymphedema French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins).

Authors:  Stéphane Vignes; Juliette Albuisson; Laurence Champion; Joël Constans; Valérie Tauveron; Julie Malloizel; Isabelle Quéré; Laura Simon; Maria Arrault; Patrick Trévidic; Philippe Azria; Annabel Maruani
Journal:  Orphanet J Rare Dis       Date:  2021-01-06       Impact factor: 4.123

2.  Indocyanine green lymphangiography is superior to clinical staging in breast cancer-related lymphedema.

Authors:  Mads Gustaf Jørgensen; Anne Pernille Hermann; Anette Riis Madsen; Steffanie Christensen; Jens Ahm Sørensen
Journal:  Sci Rep       Date:  2021-10-26       Impact factor: 4.379

3.  Accuracy, Sensitivity, and Specificity of the LLIS and ULL27 in Detecting Breast Cancer-Related Lymphedema.

Authors:  Michelle Coriddi; Leslie Kim; Leslie McGrath; Elizabeth Encarnacion; Nicholas Brereton; Yin Shen; Andrea V Barrio; Babak Mehrara; Joseph H Dayan
Journal:  Ann Surg Oncol       Date:  2021-07-15       Impact factor: 5.344

4.  Liposuction of Breast Cancer-Related Arm Lymphedema Reduces Fat and Muscle Hypertrophy.

Authors:  Tobias Karlsson; Magnus Karlsson; Karin Ohlin; Gaby Olsson; Håkan Brorson
Journal:  Lymphat Res Biol       Date:  2021-03-02       Impact factor: 2.589

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.